Dr. Reddy's Laboratories Limited
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	3/31/2022	3/31/2023	3/31/2024	3/31/2026	3/31/2027	3/31/2028
Revenue % change YoY	$214.39B N/A	$245.87B 14.68%	$279.16B 13.53%	Avg: $321.25B Low: $318.61B High: $323.01B avg. 15.07%	Avg: $321.10B Low: $293.46B High: $343.52B avg. -0.04%	Avg: $446.72B Low: $408.28B High: $477.92B avg. 39.12%
Net Income % change YoY	$23.56B N/A	$45.06B 91.22%	$55.68B 23.55%	Avg: $56.19B Low: $52.74B High: $58.21B avg. 0.92%	Avg: $48.49B Low: $43.06B High: $52.89B avg. -13.71%	Avg: $53.66B Low: $47.65B High: $58.53B avg. 10.65%
EBITDA % change YoY	$52.64B N/A	$74.43B 41.39%	$88.42B 18.79%	Avg: $97.97B Low: $97.17B High: $98.51B avg. 10.80%	Avg: $97.93B Low: $89.50B High: $104.77B avg. -0.04%	Avg: $136.24B Low: $124.52B High: $145.76B avg. 39.12%
EPS % change YoY	$142.08 N/A	$271.47 91.06%	$334.02 23.04%	Avg: $337.11 Low: $316.42 High: $349.18 avg. 0.92%	Avg: $290.89 Low: $258.35 High: $317.3 avg. -13.71%	Avg: $321.88 Low: $285.87 High: $351.1 avg. 10.65%
Operating Expenses % change YoY	$76.80B N/A	$117.61B 53.14%	$95.87B -18.48%	Avg: $100.97B Low: $100.14B High: $101.53B avg. 5.31%	Avg: $100.92B Low: $92.24B High: $107.97B avg. -0.04%	Avg: $140.41B Low: $128.33B High: $150.22B avg. 39.12%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of -0.71% in 2026-2028.

We have gathered data from 14 analysts. Their low estimate is 52.74B, average is 56.19B and high is 58.21B.

Wall Street analysts forecast annual average revenue growth of 18.05% in 2026-2028.

We have gathered data from 14 analysts. Their low revenue estimate is $318.61B, average is $321.25B and high is $323.01B.

Wall Street analysts forecast annual average earnings growth of -0.71% in 2026-2028.

We have gathered data from 14 analysts. Their low earnings per share estimate is $316.42, average is $337.11 and high is $349.18.